Comparisons of Novel Double-lumen Endobronchial Tube for Blind Lung Isolation Technique With Conventional Double-lumen Endobronchial Tube in Patients Undergoing One-lung Ventilation
Launched by YONSEI UNIVERSITY · Dec 19, 2018
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. ASA classification 1-3
- • 2. aged between 20 to 85
- • 3. undergoing one lung ventilation using left-sided double-lumen endobronchial tube for thoracic surgery
- Exclusion Criteria:
- • 1. Expected difficult intubation (neck extension\<35 degrees, mandibular-hyoid distance \< 6 cm, sternomental distance \< 12.5 cm)
- • 2. anomaly of tracheobronchial tree
- • 3. intraluminal lesion in left or right bronchus
- • 4. Obesity (Body Mass Index \> 30)
- • 5. upper respiratory infection
- • 6. Thoracic surgical history
- • 7. blood coagulation disorder
- • 8. emergency operation
About Yonsei University
Yonsei University, a prestigious institution located in South Korea, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Yonsei University leverages its extensive expertise and innovative approaches in various fields of medicine to conduct rigorous clinical trials aimed at improving patient outcomes and advancing healthcare solutions. The university's robust infrastructure, multidisciplinary collaboration, and adherence to ethical standards ensure the integrity and reliability of its research initiatives, making it a key player in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials